These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10402968)

  • 41. A comparison of re-infection rates with Schistosoma haematobium following chemotherapy in areas with high and low levels of infection.
    Mutapi F; Ndhlovu PD; Hagan P; Woolhouse ME
    Parasite Immunol; 1999 May; 21(5):253-9. PubMed ID: 10320623
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SCORE Studies on the Impact of Drug Treatment on Morbidity due to
    King CH; Binder S; Shen Y; Whalen CC; Campbell CH; Wiegand RE; Olsen A; Secor WE; Montgomery SP; Musuva R; Mwinzi PNM; Magnussen P; Kinung'hi S; Andrade GN; Ezeamama AE; Colley DG
    Am J Trop Med Hyg; 2020 Jul; 103(1_Suppl):30-35. PubMed ID: 32400348
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of single versus mixed Schistosoma haematobium and S. mansoni infections on morbidity profiles amongst school-children in Taveta, Kenya.
    Gouvras AN; Kariuki C; Koukounari A; Norton AJ; Lange CN; Ireri E; Fenwick A; Mkoji GM; Webster JP
    Acta Trop; 2013 Nov; 128(2):309-17. PubMed ID: 23313322
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High Efficacy of Praziquantel in
    Houmsou RS; Wama BE; Agere H; Uniga JA; Amuta EU; Kela SL
    Sultan Qaboos Univ Med J; 2018 Aug; 18(3):e304-e310. PubMed ID: 30607270
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Dynamics of Egg Excretion of
    Niaré DS; Doumtabe D; Ongoiba A; Sidibé K; Traoré A; Sangala J; Kayentao K; Tran TM; Crompton PD; Traoré B; Doumbo OK
    Bull Soc Pathol Exot; 2018; 111(2):114-120. PubMed ID: 30789237
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of praziquantel on hematuria and proteinuria in urinary schistosomiasis.
    Mott KE; Dixon H; Osei-Tutu E; England EC; Davis A
    Am J Trop Med Hyg; 1985 Nov; 34(6):1119-26. PubMed ID: 3938926
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Morbidity markers for Schistosoma haematobium infection.
    Vennervald BJ; Reimert CM; Ouma JH; Kilama WL; Deelder AM; Hatz C
    Trop Geogr Med; 1994; 46(4 Spec No):239-41. PubMed ID: 7825227
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of irrigated agriculture on the transmission of urinary schistosomiasis in the Middle and Upper Valleys of the Senegal River basin.
    de Clercq D; Vercruysse J; Sène M; Seck I; Sall CS; Ly A; Southgate VR
    Ann Trop Med Parasitol; 2000 Sep; 94(6):581-90. PubMed ID: 11064760
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors affecting the intensity of reinfection with Schistosoma haematobium following treatment with praziquantel.
    Chandiwana SK; Woolhouse ME; Bradley M
    Parasitology; 1991 Feb; 102 Pt 1():73-83. PubMed ID: 1903882
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reinfection with Schistosoma haematobium following school-based chemotherapy with praziquantel in four highly endemic villages in Côte d'Ivoire.
    N'Goran EK; Utzinger J; N'Guessan AN; Müller I; Zamblé K; Lohourignon KL; Traoré M; Sosthène BA; Lengeler C; Tanner M
    Trop Med Int Health; 2001 Oct; 6(10):817-25. PubMed ID: 11679130
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect on school attendance and performance of iron and multiple micronutrients as adjunct to drug treatment of Schistosoma-infected anemic schoolchildren.
    Ayoya MA; Spiekermann-Brouwer GM; Traoré AK; Garza C
    Food Nutr Bull; 2012 Dec; 33(4):235-41. PubMed ID: 23424889
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of repeated treatment with praziquantel of schistosomiasis in children under six years of age living in an endemic area for Schistosoma haematobium infection.
    Mduluza T; Ndhlovu PD; Madziwa TM; Midzi N; Zinyama R; Turner CM; Chandiwana SK; Nyazema N; Hagan P
    Mem Inst Oswaldo Cruz; 2001; 96 Suppl():157-64. PubMed ID: 11586443
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Case-Control Study of Posttreatment Regression of Urinary Tract Morbidity Among Adults in Schistosoma haematobium-Endemic Communities in Kwale County, Kenya.
    Magak P; Chang-Cojulun A; Kadzo H; Ireri E; Muchiri E; Kitron U; King CH
    Am J Trop Med Hyg; 2015 Aug; 93(2):371-6. PubMed ID: 26013375
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The usefulness of urinalysis reagent strips in selecting Schistosoma haematobium egg positives before and after treatment with praziquantel.
    Kiliku FM; Kimura E; Muhoho N; Migwi DK; Katsumata T
    J Trop Med Hyg; 1991 Dec; 94(6):401-6. PubMed ID: 1758012
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Age-acquired resistance and predisposition to reinfection with Schistosoma haematobium after treatment with praziquantel in Mali.
    Etard JF; Audibert M; Dabo A
    Am J Trop Med Hyg; 1995 Jun; 52(6):549-58. PubMed ID: 7611564
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of Praziquantel against Schistosoma haematobium in Dulshatalo village, western Ethiopia.
    Mekonnen A; Legesse M; Belay M; Tadesse K; Torben W; Teklemariam Z; Erko B
    BMC Res Notes; 2013 Sep; 6():392. PubMed ID: 24073761
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of voiding function in inhabitants infected with Schistosoma haematobium.
    Watanabe K; Muhoho ND; Mutua WR; Kiliku FM; Awazawa T; Moji K; Aoki Y
    J Trop Pediatr; 2011 Aug; 57(4):263-8. PubMed ID: 20427427
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluating the potential impact of mass praziquantel administration for HIV prevention in Schistosoma haematobium high-risk communities.
    Ndeffo Mbah ML; Gilbert JA; Galvani AP
    Epidemics; 2014 Jun; 7():22-7. PubMed ID: 24928666
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Age-targeted chemotherapy for control of urinary schistosomiasis in endemic populations.
    King CH; Muchiri EM; Ouma JH
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 4():203-10. PubMed ID: 1343896
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Late benefits 10-18 years after drug therapy for infection with Schistosoma haematobium in Kwale District, Coast Province, Kenya.
    Ouma JH; King CH; Muchiri EM; Mungai P; Koech DK; Ireri E; Magak P; Kadzo H
    Am J Trop Med Hyg; 2005 Aug; 73(2):359-64. PubMed ID: 16103604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.